Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

NBL4 Activators

Activators of NBL4 play a significant role in the regulation of the erythrocyte membrane protein band 4.1 like 4A by employing a range of biochemical strategies. Certain molecules that act to either stimulate a particular enzyme responsible for synthesizing a key signaling molecule or inhibit enzymes that degrade this molecule are key in increasing its intracellular levels. The rise in this signaling molecule results in the activation of a kinase involved in a signaling pathway that influences the function of various proteins, including NBL4. Moreover, specific activators that target a group of receptors involved in cellular signaling can initiate a cascade of events leading to the production of this crucial signaling molecule, which is central to the kinase signaling pathway and may consequently promote the activation of NBL4. The interaction of these receptors with their natural or synthetic binders can similarly amplify NBL4 activity through this established route.

Additionally, strategies that involve the use of molecules that mimic the key signaling molecule and agents that can cause a lasting activation of signaling proteins illustrate another means of achieving NBL4 activation. These methods circumvent the usual receptor-mediated processes and provide a direct and sustained elevation in the signaling molecule's levels, thereby ensuring persistent kinase signaling activity. For example, certain toxins can lock a signaling protein subunit in an activated state, leading to an intensification of NBL4 activity. Likewise, compounds that act on specific receptors, and agents that target certain receptor agonists, further confirm the wide variety of molecules that can enhance NBL4 activation by focusing on the same signaling molecule-kinase axis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Inhibits phosphodiesterase 4, leading to an increase in cAMP levels, thus potentially enhancing NBL4 activity by stimulating PKA signaling pathways.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Non-specific inhibitor of phosphodiesterases, raises intracellular cAMP levels, possibly resulting in the activation of NBL4 through PKA-dependent signaling mechanisms.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Activates adrenergic receptors which can lead to increased cAMP production and activation of PKA signaling, potentially enhancing NBL4 activity.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Beta-adrenergic agonist that increases cAMP levels and activates PKA signaling, which may contribute to the activation of NBL4.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Cell-permeable cAMP analog that activates PKA signaling, which could lead to the activation of NBL4.

Histamine, free base

51-45-6sc-204000
sc-204000A
sc-204000B
1 g
5 g
25 g
$94.00
$283.00
$988.00
7
(1)

Through its action on H2 receptors, it can increase cAMP levels, thereby possibly activating NBL4 through PKA-dependent pathways.

Adenosine

58-61-7sc-291838
sc-291838A
sc-291838B
sc-291838C
sc-291838D
sc-291838E
sc-291838F
1 g
5 g
100 g
250 g
1 kg
5 kg
10 kg
$34.00
$48.00
$300.00
$572.00
$1040.00
$2601.00
$4682.00
1
(0)

Acts on A2 receptors to increase cAMP levels, potentially leading to the activation of NBL4 through PKA signaling pathways.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$57.00
$159.00
$275.00
$678.00
37
(1)

Through EP2 and EP4 receptors, increases cAMP levels in cells, which may contribute to the activation of NBL4 via PKA signaling.

BAY 60-6583

910487-58-0sc-503262
10 mg
$210.00
(0)

A2B adenosine receptor agonist which enhances cAMP production, potentially leading to the activation of NBL4 through PKA-dependent signaling pathways.